Screener
Travere Therapeutics, Inc. TVTX Net margin
Net margin at other companies
Other financials
Where this comes from
Calculated from Travere Therapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: Travere Therapeutics, Inc.’s 10-Q, filed October 30, 2025. Open the filing →
- Filed
- Oct 30, 2025
- Fiscal quarter
- Q3 FY2025
- Calendar quarter
- Q3 2025
- Accession
- 0001438533-25-000056
FAQ
- What is Travere Therapeutics, Inc.'s net margin?
- Travere Therapeutics, Inc. (TVTX) reported net margin of -20.3% in Q3 2025.
- How has Travere Therapeutics, Inc.'s net margin changed year-over-year?
- Travere Therapeutics, Inc.'s net margin increased by 88.2% year-over-year, from -172.7% to -20.3%.
- What is the long-term trend for Travere Therapeutics, Inc.'s net margin?
- Over 3 years (2020 to 2024), Travere Therapeutics, Inc.'s net margin has grown at a 17.3% compound annual growth rate (CAGR), from -85.4% to -137.9%.
- What does net margin mean?
- Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.
Ask your AI about Travere Therapeutics, Inc.'s net margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude